Stevens Capital Management LP Biogen Inc. Transaction History

Stevens Capital Management LP

$703 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $628,639 - $793,760	2,965 Added 47.03%	9,269 $2 Million
Q4 2023 Feb 02, 2024	BUY	$222.59 - $267.94 $1.4 Million - $1.69 Million	6,304 New	6,304 $1.63 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $604,999 - $699,095	2,198 New	2,198 $626,000
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $218,484 - $259,818	-1,165 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $225,742 - $284,423	1,165 New	1,165 $245,000
Q4 2021 Jan 28, 2022	SELL	$223.92 - $287.77 $625,632 - $804,029	-2,794 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $790,674 - $1.03 Million	2,794 New	2,794 $791,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $396,788 - $635,335	-1,532 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $372,199 - $436,053	1,532 New	1,532 $429,000
Q1 2020 Apr 21, 2020	SELL	$268.85 - $341.04 $3.14 Million - $3.99 Million	-11,686 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $2.57 Million - $3.55 Million	11,686 New	11,686 $3.47 Million
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $261,568 - $409,124	-1,207 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $336,149 - $425,769	1,207 New	1,207 $363,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $7.24 Million - $9.47 Million	-24,681 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $3.81 Million - $4.54 Million	14,794 Added 149.63%	24,681 $7.16 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $302,531 - $427,879	1,163 Added 13.33%	9,887 $2.71 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $1.51 Million - $1.69 Million	-4,911 Reduced 36.02%	8,724 $2.78 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $3.83 Million - $4.5 Million	13,635	13,635 $4.27 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Account